Interestingly, the succinate receptor (GPR91) expression was increased in patients with coronary artery disease and diabetes, and the authors showed that antagonising GPR91 signalling offers a promising therapeutic strategy [169]. This evidence concerns the gene SUCNR1 and coronary artery disorder.